TEVA
Teva Pharma Industries Ltd
36.50$
-0.6%
vs. previous close
Closing price · As of: Aug 13, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 51.9% | 45.8% | 53.6% | 51.4% | 50.4% | 49.9% | 51.8% | 49.7% | 48.6% | 43.6% | 50.5% | 48.0% | 47.5% | |
| 48.1% | 54.2% | 46.4% | 48.6% | 49.6% | 50.1% | 48.2% | 50.3% | 51.4% | 56.4% | 49.5% | 52.0% | 52.5% | |
| 6.6% | 5.3% | 6.3% | 6.5% | 5.5% | 6.4% | 6.3% | 5.8% | 5.7% | 5.7% | 5.6% | 6.0% | 5.7% | |
| 7.0% | 6.6% | 7.3% | 6.8% | 6.9% | 7.1% | 7.6% | 7.3% | 7.1% | 7.8% | 7.6% | 7.7% | 7.5% | |
| 39.1% | 37.2% | 52.1% | 48.7% | 50.8% | 50.8% | 34.9% | 39.4% | 31.7% | 50.0% | 33.1% | 48.4% | 41.0% | |
| 8.9% | 17.0% | -5.7% | -0.1% | -1.2% | -0.7% | 13.3% | 10.9% | 19.7% | 6.4% | 16.4% | 3.6% | 11.5% | |
| 7.3% | 5.8% | 6.5% | 5.8% | 6.3% | 18.0% | 5.8% | 4.9% | 4.7% | 6.2% | 5.0% | 4.8% | 5.2% | |
| 1.7% | 11.4% | -12.3% | -5.9% | -7.4% | -5.8% | 7.6% | 4.9% | 14.5% | 1.9% | 11.0% | -11.0% | 4.2% | |
| -0.3% | 0.9% | -1.4% | 15.1% | 1.6% | 0.7% | 1.9% | -1.9% | 4.8% | -8.3% | 1.7% | 2.9% | 0.1% | |
| 1.8% | 10.4% | -3.6% | -20.3% | -10.1% | -5.1% | 5.5% | 6.8% | 9.7% | 10.2% | 9.3% | -13.9% | 4.1% | |
| 16.3% | 34.0% | 1.4% | 5.9% | 4.8% | 27.5% | 24.5% | 15.7% | 24.6% | 13.4% | 22.0% | -0.5% | 15.0% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.